ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,505.22
1.35%
Dow Jones
43,487.83
0.78%
Gold vs US Dollar
2,705.225
0.34%
Brent Oil
79.815
-0.50%
Bitcoin
102,449.62
1.43%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaxart Inc (VXRT)

  7. Vaxart Inc (VXRT) News

Vaxart (VXRT)

Vaxart Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VXRT
DateTimeSourceHeadlineSymbolCompany
14/01/202518:40AllPennyStocks.comThis California-Based Biotech Found Massive Success Following DSMB ApprovalNASDAQ:VXRTVaxart Inc
14/01/202513:00GlobeNewswire Inc.Vaxart Highlights Progress of COVID-19, Norovirus and Influenza ProgramsNASDAQ:VXRTVaxart Inc
14/01/202500:55GlobeNewswire Inc.Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical TrialNASDAQ:VXRTVaxart Inc
31/12/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
27/12/202414:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
17/12/202421:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
02/12/202421:01GlobeNewswire Inc.Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
19/11/202413:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
13/11/202421:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
13/11/202421:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
07/11/202413:00GlobeNewswire Inc.Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13NASDAQ:VXRTVaxart Inc
24/10/202412:00GlobeNewswire Inc.Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024NASDAQ:VXRTVaxart Inc
15/10/202412:00GlobeNewswire Inc.Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet NeedNASDAQ:VXRTVaxart Inc
08/10/202420:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
08/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
30/09/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
30/09/202420:12GlobeNewswire Inc.Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
30/08/202412:00GlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
28/08/202412:00GlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical DysplasiaNASDAQ:VXRTVaxart Inc
08/08/202420:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
08/08/202420:01GlobeNewswire Inc.Vaxart Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
02/08/202412:00GlobeNewswire Inc.Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8NASDAQ:VXRTVaxart Inc
20/06/202410:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
17/06/202420:05GlobeNewswire Inc.Vaxart Provides Business UpdateNASDAQ:VXRTVaxart Inc
17/06/202410:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VXRTVaxart Inc
14/06/202410:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
13/06/202423:07GlobeNewswire Inc.Vaxart Announces $40 Million Underwritten Offering of Common StockNASDAQ:VXRTVaxart Inc
13/06/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
13/06/202420:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VXRTVaxart Inc
13/06/202420:15GlobeNewswire Inc.Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
 Showing the most relevant articles for your search:NASDAQ:VXRT

Your Recent History

BIT
NSCIT6980436
Intesa Sanpaolo
BIT
NSCIT2591229
Intesa Sanpaolo
BIT
Q00292
Leonteq Securities
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads